Welcome to the ValueWiki Anesiva, Inc. (ANSV) article! Register for free or click the "edit" link to contribute!    

Anesiva, Inc. (ANSV)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Anesiva, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max





Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

12/01/08 8:12 am Zacks #1 Rank Additions for Monday (Zacks.com)
11/21/08 9:11 am ANESIVA, INC. Financials (EDGAR Online Financials)
11/21/08 7:11 am Zacks #1 Rank Additions for Friday (Zacks.com)
11/20/08 7:11 am PDL hopes to spin off biotech unit by Dec. 18 (at bizjournals.com)
11/19/08 7:11 am Zacks #1 Rank Additions for Wednesday (Zacks.com)
11/14/08 4:11 pm ANESIVA, INC. Files SEC form 8-K/A, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an (EDGAR Online)
11/14/08 4:11 pm ANESIVA, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
11/13/08 6:11 am Zacks #1 Rank Additions for Thursday (Zacks.com)
11/11/08 4:11 am PDL names McLaughlin as CEO-to-be (at bizjournals.com)
11/10/08 6:11 pm UPDATE - Anesiva pain drug fails late-stage trial, cuts jobs (at Reuters)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Anesiva, Inc. Snapshot
Anesiva, Inc. Leadership
Anesiva, Inc. Fundamentals
Anesiva, Inc. Technical Analysis
Anesiva, Inc. Message Boards

Notes

  1. This is a sample reference.
Personal tools